Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Ltd.10.904511404518.1936
Domestic EquitiesApollo Hospitals Enterprise Ltd.5.3462128158.9199
Domestic EquitiesCipla Ltd.5.3320671928.8962
Domestic EquitiesMax Healthcare Institute Ltd.5.3003924278.8434
Domestic EquitiesDivi's Laboratories Ltd.5.1485141968.5900
Domestic EquitiesDr. Reddy's Laboratories Ltd.4.7064644647.8524
Domestic EquitiesLupin Ltd.3.8519298536.4268
Domestic EquitiesTorrent Pharmaceuticals Ltd.3.3415140765.5752
Domestic EquitiesFortis Healthcare Ltd.2.9760583144.9654
Domestic EquitiesLaurus Labs Ltd.2.4117416974.0238
Domestic EquitiesAurobindo Pharma Ltd.2.2481310583.7509
Domestic EquitiesGlenmark Pharmaceuticals Ltd.2.2285184443.7181
Domestic EquitiesAlkem Laboratories Ltd.1.933856833.2265
Domestic EquitiesMankind Pharma Ltd.1.8733147153.1255
Domestic EquitiesIPCA Laboratories Ltd.1.4615165792.4384
Domestic EquitiesBiocon Ltd.1.3971635502.3310
Domestic EquitiesZydus Lifesciences Ltd.1.2690239152.1172
Domestic EquitiesGland Pharma Ltd.0.975188101.6269
Domestic EquitiesAster DM Healthcare Ltd.0.9169277061.5298
Domestic EquitiesNarayana Hrudayalaya ltd.0.900785001.5027
Domestic EquitiesAjanta Pharma Ltd.0.866451961.4455
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Ltd.0.724450331.2087
Domestic EquitiesPiramal Pharma Ltd.0.6590710811.0995
Domestic EquitiesSyngene International Ltd.0.6114215471.0201
Domestic EquitiesGlobal Health Ltd.0.605295821.0098
Total 67.9894 113.4373
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd.0.2696 0.4498
Cash & Cash Equivalents and Net AssetsAccrued Interest0.0001 0.0001
Cash & Cash Equivalents and Net AssetsNet Receivables/(Payables)-0.0803 -0.1339
Total 0.1894 0.3160
Overseas EquitiesELI LILLY & CO6.2724109810.4653
Overseas EquitiesJOHNSON & JOHNSON4.115532886.8666
Overseas EquitiesABBVIE INC2.961524114.9412
Overseas EquitiesNOVARTIS AG2.125125953.5457
Overseas EquitiesMERCK & CO.INC2.071134103.4556
Overseas EquitiesTHERMO FISHER SCIENTIFIC INC1.64455162.7437
Overseas EquitiesNovo Nordisk A/S1.439043962.4009
Overseas EquitiesABBOTT LABORATORIES1.430423762.3866
Overseas EquitiesAMGEN INC1.38407352.3092
Overseas EquitiesINTUITIVE SURGICAL INC1.36084902.2705
Overseas EquitiesGILEAD SCIENCES INC1.324516942.2098
Overseas EquitiesDANAHER CORP1.06108801.7702
Overseas EquitiesMEDTRONIC PLC0.993017511.6568
Overseas EquitiesSTRYKER CORP0.95674701.5962
Overseas EquitiesVERTEX PHARMACEUTICALS INC0.90843511.5157
Overseas EquitiesRegeneron Pharmaceuticals Inc0.58401430.9744
Overseas EquitiesBECTON DICKINSON AND CO0.43933920.7330
Overseas EquitiesIQVIA HOLDINGS INC0.29542330.4928
Overseas EquitiesAGILENT TECHNOLOGIES INC0.28613880.4773
Overseas EquitiesILLUMINA INC0.16832110.2808
Total 31.8212 53.0923
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.